. Author manuscript; available in PMC: 2010 Jul 1.

Published in final edited form as: Neurobiol Learn Mem. 2009 Feb 25;92(1):89–98. doi: 10.1016/j.nlm.2009.02.005

Table 1.

Mean (+SE) of choice run latencies for the four treatment groups beginning on P26 in Experiment 2 as a function of training phase (acquisition or reversal), 12-trial blocks, and dose.

	ACQUISITION				REVERSAL
	Block 1	Block 2	Block 3	Block 4	Block 1	Block 2	Block 3	Block 4	n
SAL-SAL	4.862 ± 0.676	4.108 ± 0.323	3.502 ± 0.215	3.402 ± 0.174	3.695 ± 0.381	3.694 ± 0.422	3.212 ± 0.382	2.832 ± 0.151	13
SAL-MK	5.887 ± 1.112	4.838 ± 0.580	4.311 ± 0.979	3.501 ± 0.328	2.998 ± 0.177	2.679 ± 0.058	2.680 ± 0.070	2.621 ± 0.060	11
MK-SAL	3.673 ± 0.208	3.356 ± 0.261	2.868 ± 0.088	2.809 ± 0.112	3.930 ± 0.312	3.658 ± 0.209	3.075 ± 0.130	2.859 ± 0.060	12
MK-MK	3.851 ± 0.209	4.905 ± 1.492	2.951 ± 0.091	2.960 ± 0.138	3.062 ± 0.097	2.868 ± 0.086	2.764 ± 0.059	2.720 ± 0.073	14